Artemether-Lumefantrine Supplier and Exporter to Nigeria

Nigeria carries the highest malaria burden of any country in the world, accounting for a substantial share of global malaria cases. Artemisinin-based combination therapies such as Artemether-Lumefantrine are the cornerstone of Nigeria's malaria case management, used across the public health system, private retail pharmacies, and donor-funded programmes. Demand for quality-assured ACTs in Nigeria is large and continuous, spanning national and state tenders, importers, and the private market.

Pharmaceutical products imported into Nigeria require registration with the National Agency for Food and Drug Administration and Control (NAFDAC). We work with Nigerian importer and distributor partners to register Artemether-Lumefantrine for the Nigerian market, providing the CTD and ACTD dossiers NAFDAC requires, and our regulatory team supports partners through the registration process. If you are an established Nigerian importer looking to add a WHO-GMP ACT to your portfolio, we would like to hear from you.

We manufacture Artemether-Lumefantrine in 20/120 mg, 40/240 mg, and 80/480 mg strengths, in both standard tablets and dispersible tablets formulated for paediatric dosing, an important requirement given the high malaria burden among Nigerian children under five. Packaging and labelling can be configured to your market requirements.

Once registered, Artemether-Lumefantrine can be supplied for national and state government malaria tenders, donor and NGO health programmes, and private-market distribution in Nigeria. We offer competitive volume pricing, flexible packaging, and private labelling for Nigerian distributors and brand owners.

MOQ and pricing depend on strength, formulation, packaging, and volume. We handle export logistics and documentation for shipments to Nigeria. Request a quote with your requirements for exact pricing and terms.